1. Home
  2. SONY vs AMGN Comparison

SONY vs AMGN Comparison

Compare SONY & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONY
  • AMGN
  • Stock Information
  • Founded
  • SONY 1946
  • AMGN 1980
  • Country
  • SONY Japan
  • AMGN United States
  • Employees
  • SONY N/A
  • AMGN N/A
  • Industry
  • SONY Consumer Electronics/Appliances
  • AMGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SONY Consumer Staples
  • AMGN Health Care
  • Exchange
  • SONY Nasdaq
  • AMGN Nasdaq
  • Market Cap
  • SONY 152.4B
  • AMGN 156.2B
  • IPO Year
  • SONY 1958
  • AMGN N/A
  • Fundamental
  • Price
  • SONY $24.85
  • AMGN $305.70
  • Analyst Decision
  • SONY Strong Buy
  • AMGN Buy
  • Analyst Count
  • SONY 2
  • AMGN 21
  • Target Price
  • SONY $28.00
  • AMGN $323.26
  • AVG Volume (30 Days)
  • SONY 7.4M
  • AMGN 2.9M
  • Earning Date
  • SONY 05-13-2025
  • AMGN 05-01-2025
  • Dividend Yield
  • SONY 0.48%
  • AMGN 3.11%
  • EPS Growth
  • SONY 24.54
  • AMGN N/A
  • EPS
  • SONY 1.18
  • AMGN 7.56
  • Revenue
  • SONY $87,824,616,162.00
  • AMGN $33,424,000,000.00
  • Revenue This Year
  • SONY $0.99
  • AMGN $7.36
  • Revenue Next Year
  • SONY $1.21
  • AMGN $2.18
  • P/E Ratio
  • SONY $21.03
  • AMGN $40.44
  • Revenue Growth
  • SONY 9.75
  • AMGN 18.57
  • 52 Week Low
  • SONY $15.02
  • AMGN $253.30
  • 52 Week High
  • SONY $25.78
  • AMGN $346.85
  • Technical
  • Relative Strength Index (RSI)
  • SONY 53.67
  • AMGN 46.10
  • Support Level
  • SONY $25.08
  • AMGN $304.29
  • Resistance Level
  • SONY $25.44
  • AMGN $315.00
  • Average True Range (ATR)
  • SONY 0.37
  • AMGN 5.71
  • MACD
  • SONY -0.04
  • AMGN -1.91
  • Stochastic Oscillator
  • SONY 51.31
  • AMGN 29.15

About SONY Sony Group Corporation

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments.

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Share on Social Networks: